SNN Smith & Nephew SNATS, Inc.
$30.10▼ -1.21%
Healthcare
Other
After hours
$30.10▲ +0.00%
Oct 27, 4:00 PM ET
Volume 852.9K
Avg Volume (10D) 1.16M
Key Metrics & Fundamentals
Market Cap
$12.60B
P/E Ratio
20.5
Div Yield
2.61%
52W Range
26.12 - 37.09
% vs 50 MA
6.43%
% vs 200 MA
-3.24%
RSI-14
65.3
MACD Histogram
+0.3300
Beta (1Y vs SPY)
0.31
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News

What Do Johnson & Johnson (JNJ) Cancer Trial Wins Mean For Its Stock?
Simply Wall St. · Oct 26, 2026 3:12 PM ET

Shell And 2 More British Undervalued Stocks To Watch
Simply Wall St. · Oct 26, 2026 1:09 PM ET

Smith & Nephew (LSE:SN.) Stays Independent, Is It 8% Undervalued?
Simply Wall St. · Oct 25, 2026 12:05 PM ET

Smith & Nephew (LSE:SN.) Stock May Be 34% Below Fair Value As Merger Talks Collapse
Simply Wall St. · Oct 25, 2026 10:09 AM ET
J&J’s Smith & Nephew Deal Collapsed Over One Executive. Here’s What It Means for the DePuy Spin
TIKR · Oct 24, 2026 3:38 AM ET
Sector Update: Healthcare Stocks Fall Late Afternoon
MT Newswires · Oct 23, 2026 3:56 PM ET
Sector Update: Healthcare Stocks Decline Friday Afternoon
MT Newswires · Oct 23, 2026 1:51 PM ET
Smith And Nephew Merger Talks With Johnson & Johnson Collapse Over Leadership Dispute
TIKR · Oct 23, 2026 1:06 PM ET
European Stocks Close Lower in Friday Trading Amid Rising Oil Prices, 'Extraordinary Collapse' in UK Consumer Confidence
MT Newswires · Oct 23, 2026 12:02 PM ET
Correction: Update: Market Chatter: Johnson & Johnson Orthopedics, Smith & Nephew Merger Collapsed Over Leadership Dispute
MT Newswires · Oct 23, 2026 10:41 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.